Avanafil vs Tibolone: side-by-side comparison
Avanafil (Phosphodiesterase type 5 (PDE5) inhibitor) and Tibolone (Synthetic steroid (STEAR)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Avanafil | Tibolone |
|---|---|---|
| Therapeutic class | Phosphodiesterase type 5 (PDE5) inhibitor | Synthetic steroid (STEAR) |
| CAS | 330784-47-9 | 5630-53-5 |
| ATC | G04BE10 | G03CX01 |
| Molecular weight | 483.95 g/mol | 312.45 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Avanafil and Tibolone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Avanafil acts by a different mechanism than Tibolone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Avanafil: Avanafil selectively inhibits phosphodiesterase type 5 (PDE5) in the corpus cavernosum, increasing cGMP and enhancing nitric-oxide-mediated vasodilation in response to sexual stimulation. Tibolone: Tibolone is a prodrug; on absorption it is rapidly converted to three active metabolites (3α-OH-tibolone, 3β-OH-tibolone and Δ4-tibolone) with different tissue-selective activity.
Indications compared
Avanafil: Avanafil is approved for erectile dysfunction in adult men. Tibolone: Tibolone is approved (in countries where licensed) for treatment of moderate-to-severe vasomotor menopausal symptoms and prevention of postmenopausal osteoporosis in women at least 12 months past their last natural menst…
Safety profile
Avanafil: The most common adverse effects are headache, flushing, nasal congestion and back pain — typical of the PDE5 class but generally less frequent than with older agents. Tibolone: Common adverse effects include vaginal bleeding or spotting (especially in the first 3 months), breast tenderness, weight changes, headache and dizziness.
Frequently asked questions
Is Avanafil better than Tibolone? ▾
Avanafil and Tibolone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Avanafil and Tibolone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Avanafil
Products with Tibolone
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.